HARMONY BIOSCIENCES HOLDINGS, INC. Inventory, Raw Materials, Gross
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Inventory, Raw Materials, Gross of $1.12 million as of 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Notes › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-02-24
- 2025-09-30: Inventory, Raw Materials, Gross $1.12M.
- 2025-06-30: Inventory, Raw Materials, Gross $901.00K.
- 2025-03-31: Inventory, Raw Materials, Gross $912.00K.
- 2024-12-31: Inventory, Raw Materials, Gross $944.00K.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2025-09-30 | $1.12M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $901.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $912.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $944.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.03M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $1.14M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.01M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $1.06M 10-K · filed 2025-02-25 |
| 2023-09-30 | $932.00K 10-Q · filed 2023-10-31 |
| 2023-06-30 | $982.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $776.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $838.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $605.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $606.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $810.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $986.00K 10-K · filed 2023-02-21 |
| 2021-09-30 | $1.02M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $712.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $773.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $396.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $185.00K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $384.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |